How have we never heard of you before?

Six weeks. Three audiences. Sixty qualified conversations. One conference presence that made a startup look like a market leader.

Being unknown is expensive

You have a 10x10 booth, a technology almost nobody in the hall recognises, and three days to change that. Around you sit companies ten times your size, with the budgets to match. This is exactly where Nanocrine stood at the American Society for Cell Biology (ASCB) Annual Meeting.

Nanocrine had built something genuinely new: spatial biology for real-time single-cell secretomics. In plain terms, a platform that measures what individual cells secrete, as they secrete it, in living tissue. No other commercial platform does this. But the science being sound and the room knowing it exists are two different problems. At a show like ASCB, a buyer who cannot place you within thirty seconds walks to the next booth. Good science with weak positioning still loses the conversation.

Nanocrine also faced a segmentation challenge that most conference strategies ignore. Their technology is relevant to cancer drug resistance researchers, stem cell quality control scientists, and wound healing biologists. They are three different buyers, with different problems, different language, and different reasons to stop walking.

Win before you arrive

Strivenn ran the programme in three phases over six weeks, from a blank positioning brief to a fully deployed, booth-ready presence.

Phase one: own something specific

Before a single asset was written, Strivenn clarified what Nanocrine could credibly own and who would care at ASCB. This meant mapping the segments in the hall, the competitors buyers would inevitably raise, and the specific measurement gaps each audience group lived with every day. Cancer researchers losing the critical drug-resistance window. Stem cell scientists discovering batch failures only after costly protocols complete. Wound healing biologists sacrificing spatial organisation to measure total protein content. Three different frustrations. Three distinct entry points into the same technology.

Phase two: architecture before assets

With positioning locked, Strivenn built a complete content architecture for the conference: application-specific handouts for each of the three audience segments, a peer-reviewed whitepaper, a technology explainer, booth banners, coordinated social content, and a new webpage describing the services. Each handout carried distinct competitive framing and a tailored “who, where, when, how” framework for the specific research problems of that segment. The same underlying science. Three different conversations.

One deliberate choice illustrates the standard of the work. The whitepaper includes an honest technical limitation section disclosing that small cytokines and growth factors below 50 kDa fall outside current single-cell detection capabilities. Most agencies would never recommend a client publish that in a conference document. Strivenn did, because a credible claim beats a broad one, and researchers notice intellectual honesty in a room full of marketing hyperbole. That section built more trust than any superlative could have.

Before any of it reached the conference floor, every piece of messaging was pressure-tested against synthetic customers built with PersonaAI, each modelled on the real buyer types Nanocrine would encounter at ASCB. The language earned its place before it was approved and went to print.

Phase three: make the room stop

The booth led with one question designed to stop people walking past: Do you know what your cells are saying? A provocation, by design. Visitors who stopped were met with collateral that already spoke their language, because Strivenn had built it for their specific problem rather than a generic life science audience.

This is what conferences can do that digital channels cannot replicate. When a researcher holds a handout written for their exact research question, hears a conversation in their own scientific vocabulary, and walks away with a whitepaper that acknowledges the technology’s current limitations honestly, something happens that a LinkedIn post and a landing page are structurally incapable of creating. They have met the company. The trust ceiling is categorically higher.

Sixty qualified leads

Nanocrine left ASCB with more than 60 qualified leads. Each one was a real conversation, captured with notes: research context, problem fit, and next-step intent. What Strivenn delivered at the end of the programme was a tiered, annotated pipeline ready for structured follow-up. Within days of the final session, leads were prioritised and segmented into pursuit tracks. What Nanocrine does with that pipeline is a commercial decision that belongs to them. What Strivenn delivered was the qualified foundation to build it from.

From banners to whitepaper to social and webpage, the presence was cohesive and professional, the kind of thing that usually takes months to build in-house.

Easy to say yes to

The companies that win a conference are the ones easiest to understand and say yes to. Clarity travels faster than size. But clarity built for the wrong audience is just noise with better typography. The Nanocrine programme worked because it combined speed with specificity: six weeks to build a segmented commercial architecture that met three distinct buyers where they actually were, rather than where it was convenient to address them.

Get the positioning right, get the segmentation right, get the assets behind both, and the room asks the only question that matters.

Ready to own your next conference?

Book a strategy call to see what we could do for your next show.